Bovespa Index Ends the Week 1.27% Higher at 132730.36 — Data Talk
The Bovespa Index is up 1664.92 points or 1.27% this week to 132730.36
--Largest one-week point and percentage gain since the week ending Aug 16, 2024
--Up six of the past eight weeks
--Today it is down 279.42 points or 0.21%
--Down seven of the past nine trading days
--Off 3.36% from its record close of 137343.96 hit Wednesday, Aug. 28, 2024
--Off 3.36% from its 52-week high of 137343.96 hit Wednesday, Aug. 28, 2024
--Up 17.95% from its 52-week low of 112531.52 hit Monday, Oct 30, 2023
--Rose 13.87% from 52 weeks ago
--Off 3.36% from its 2024 closing high of 137343.96 hit Wednesday, Aug 28, 2024
--Up 11.41% from its 2024 closing low of 119137.86 hit Monday, June 17, 2024
--Month-to-date it is down 2.41%
--Year-to-date it is down 1454.88 points or 1.08%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 27, 2024 17:22 ET (21:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks